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Abstract
Background: Enzyme production in microbial cells has been limited to secreted enzymes or
intracellular enzymes followed by expensive down stream processing. Extracellular enzymes
consists mainly of hydrolases while intracellular enzymes exhibit a much broader diversity. If these
intracellular enzymes could be secreted by the cell the potential of industrial applications of
enzymes would be enlarged. Therefore a novel secretion pathway for intracellular proteins was
developed, using peroxisomes as secretion vesicles.
Results: Peroxisomes were decorated with a Golgi derived v-SNARE using a peroxisomal
membrane protein as an anchor. This allowed the peroxisomes to fuse with the plasma membrane.
Intracellular proteins were transported into the peroxisomes by adding a peroxisomal import signal
(SKL tag). The proteins which were imported in the peroxisomes, were released into the extra-
cellular space through this artificial secretion pathway which was designated peroxicretion. This
concept was supported by electron microscopy studies.
Conclusion: Our results demonstrate that it is possible to reroute the intracellular trafficking of
vesicles by changing the localisation of SNARE molecules, this approach can be used in in vivo
biological studies to clarify the different control mechanisms regulating intracellular membrane
trafficking. In addition we demonstrate peroxicretion of a diverse set of intracellular proteins.
Therefore, we anticipate that the concept of peroxicretion may revolutionize the production of
intracellular proteins from fungi and other microbial cells, as well as from mammalian cells.
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The specificity of intracellular membrane trafficking is
determined by multiple layers of control mechanisms that
ensure that only appropriate organelles fuse with specific
target compartments. These include Rab-GTPases [1]
operating in conjunction with polyphosphoinositides [2]
and Rab effectors [3] that frequently include multiprotein
complexes. In eukaryotes, membrane fusion of secretory
vesicles is mediated by SNARE-proteins [4] and specificity
of membrane fusion is obtained by specific SNARE-pro-
tein interactions. In yeast, fusion of post-Golgi trafficking
vesicles requires at least 10 genes including the Rab-
GTPase Sec4 [5] the Exocyst multiprotein complex [6] and
the SNAREs Snc1/2 [7] on the transport vesicle and Sso1/
2 [8] and Sec9 [9] on the plasma membrane. Moreover
organelles can only fuse with target membranes once they
are transported into close proximity, involving directed
transport along cytoskeletal tracts [10]. The formation of
the resulting SNARE-pin subsequently triggers membrane
fusion [11]. The ER supplies the secretory route with
membrane enclosed vesicles which travel from the ER via
the Golgi towards the cell membrane.
The ER is very different from the cytosol regarding post-
translational protein modifications. N-glycosylation of
proteins in the ER is important for folding, degradation and
quality control [12]. The cytosol does not contain an N-gly-
cosylation machinery and as a consequence, soluble
cytosolic proteins are not N-glycosylated [13]. In addition,
the reducing environment of the cytosol is very different
from that in the ER and Golgi, where oxidizing conditions
and specialized folding enzymes like Pdi1 and Ero1 facili-
tate disulfide bridge formation [14]. These fundamental
differences between secretory pathway and cytosol compli-
cate the routing of cytosolic proteins through the secretory
pathway to yield active, secreted enzymes. In fact, literature
does not describe any successful extracellular production of
an intracellular protein through the secretory pathway.
Cytosolic proteins preferentially fold into their active con-
formation with the aid of specific chaperones and folding
enzymes, under the reducing conditions which are normal
to the cytosol [15]. Recently it has been described that per-
oxisomes also may have their origin in the ER [16]. How-
ever they do not fuse with other compartments and SNARE
molecules have not been detected on peroxisomes [17].
The peroxisome has all the necessary features to enable
import of completely folded and mature intracellular pro-
teins [18]. Proteins of the peroxisomal lumen contain
either a PTS1 [19] or a PTS2 signal [20]. The PTS1 signal is
a specific tripeptide located at the C-terminal end of the
protein, and is recognized by the Pex5 receptor, a transloca-
tor for PTS1 containing proteins [21]. The ER origin of per-
oxisomes, combined with their capacity to import
completely folded proteins, would render them ideally
suited for secretion of intracellular proteins.
To enable this we have decorated Aspergillus niger peroxi-
somes with the A. niger ortholog of the v-SNARE Snc1
(SncA), by expressing it as a chimera with the A. niger
ortholog of the peroxisomal membrane protein Pmp22
(PmpA) [22]. In Figure 1 panel C a schematic representa-
tion of the fusion of peroxisomes with the plasmame-
brane is shown. The modified peroxisomes were able to
fuse with the plasma membrane as evidenced by electron
microscopy and extracellular secretion of peroxisomal
accumulated proteins, which were tagged with the PTS1-
signal peptide -SKL. We have named this novel technol-
ogy peroxicretion, for peroxisome-mediated intracellular
protein secretion.
Results
PTS 1 mediated peroxisomal import in A. niger
The PTS1 receptor Pex5 is responsible for recognition and
transport of PTS1-containing proteins into peroxisomes
[21]. To confirm that PTS1 signals will result in peroxiso-
mal localization in A. niger we have identified a Pex5
ortholog in the genome of A. niger (Genbank 4989140).
Amino acids important for PTS1 recognition are con-
served in the Pex5 ortholog (figure 1), suggesting that the
presence of an -SKL sequence at the C-terminus of model
proteins will lead to peroxisomal localization. Indeed,
expressing -SKL tagged eGFP in A. niger (figure 2) caused
a punctated pattern typical for peroxisomal localization.
This result indicated that -SKL mediated peroxisomal tar-
geting occurs in A. niger as expected based on the presence
of a Pex5 receptor ortholog.
Decoration of A. niger peroxisomes with v-SNARE 
molecules
To enable fusion of peroxisomes with the plasma mem-
brane it was necessary to identify a peroxisomal mem-
brane anchor, which could be used to place the v-SNARE
SncA on the peroxisome. This peroxisomal membrane
anchor should have the N-terminus positioned towards
the cytosol, enabling N-terminal fusions. The resulting
chimeric protein is anchored in the peroxiomal mem-
brane with the N-terminal fused SncA positioned at the
cytosolic side of the peroxisome. Using the CBS prediction
server http://www.cbs.dtu.dk/services/ we predicted the
topology of the A. niger ortholog of Pmp22, which has
been studied in Arabidopsis and in mammalian cells
[22,23]. A membrane topology was predicted of 4 TMD's
with the N-terminus positioned at the cytosolic side of the
peroxisome. PmpA contains two peroxisomal targeting
regions with similar clusters of basic amino acids, interact-
ing with Pex19p [22]. This prediction is in agreement with
experimental evidence determining the topology of
Pmp22 in Arabidopsis and mammalian cells [22,23]. To
determine whether the Pmp22p ortholog of A. niger local-
ises to the peroxisomes we constructed an eGFP-pmpA chi-
mera and expressed this fusion gene in A. niger. WePage 2 of 11
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Alignment of the PEX5 orthologs of S. cerevisiae, A. niger and K. lactisFigure 1
Alignment of the PEX5 orthologs of S. cerevisiae, A. niger and K. lactis. Identical aminoacids are indicated with *, highly 
similar aminoacids are indicated with :, similar aminoacids are indicated with •. The conserved aminoacids which are important 
for PTS1 recognition are colored in yellow.
K. lactis       ---------------------------------MSADCSVGSNP-LAQLNKHAQQNPALR 
S. cerevisiae   ---MDVGSCSVGNNPLAQLHKHTQQNKSLQFN-QKNNGRLNESP-LQGTNKPGISEAFIS 
A. niger        MSFLGGAECSTAGNPLTQFTKHVQDDKSLQRDRLVGRGPGGMQEGMRSRGMMGGQDQMMD 
                                                        . .  :   .  . .:  :  
                QVGYQN-PASNVAQNFKTHVNEVSNANRFQMDQFMNRSPGFS---DGQLGMAPVPSAILS 
                NVNAISQENMANMQRFINGEPLIDDKRRMEIGPSSGRLPPFSNVHSLQTSANPTQIKGVN 
                EFAQQPGQIPGAPPQPFAMEQLRRELDQFQTTPPRTGSPGWAAEFDAGEHARMEAAFAGP 
                :.            .         :  :::        * ::   .               
                HGPRFGLK--KQDSGSSNMSAGDTAQHSRSWGNEFNSRSPQQGLASRVNNVERISNTNSM 
                DISHWSQE--FQGSNSIQNRNADTGNSEKAWQRGSTTASSRFQYPNTMMNNYAYASMNSL 
                QGPMMNNASGFTPAEFARFQQQSRAGMPQTANHVASAPSPMMAGYQRPMGMGGYMGMGGM 
                . .  .       :   .    . .   ::  .  .: *.     .   .     . ..: 
                SSYRPGMSRIGRPMMHTGISSLHN------YSHMSQQTPQMSSDDGVLADKQWNEQFEAL 
                SGSRLQSPAFMNQQQSGRSKEGVN------EQEQQPWTDQFEKLEKEVSENLDINDEIEK 
                GMMPQTFNPMAMQQQPAEATTQDKGKGRMVELDDENWEAQFAEMETADTQKLDDEANAAV 
                .        :         .   :        . .    *: . :   :::   :      
                EKAVAENLTMEDNKEETKEEIVVEDGYQADFQEVWD---KLQAETADNNLETSDS-QWEK 
                EENVSEVEQNKPETVE-KEEGVYGDQYQSDFQEVWDSIHKDAEEVLPSELVNDDL-NLGE 
                EAELNDLDRSVPQDSGDSAFESVWQRVQAETATNRKLAEGETDFNIDDNLHMGEMGEWDG 
                *  : :      :    .      :  *::     .           .:*  .:  :    
                DYARYMTGKATHIPPYRFDNDNQYMHNPNAYEIGCILMENGAKLSEAALAFEAAVQEDPA 
                DYLKYLGGRVNGNIEYAFQSNNEYFNNPNAYKIGCLLMENGAKLSEAALAFEAAVKEKPD 
                FDTLNTRFRNPQLGDYMFEEDNVFRSVSNPFEEGVKIMREGGNLSLAALAFEAAVQKDPQ 
                        :      * *:.:* :   .*.:: *  :*.:*.:** *********::.*  
                HVDAWLKLGLVQTQNEKEMNGISALEQCLSLDPTNQQALMTISISYINEGYDLTAFSMLN 
                HVDAWLRLGLVQTQNEKELNGISALEECLKLDPKNLEAMKTLAISYINEGYDMSAFTMLD 
                HVQAWTMLGSAQAQNEKELPAIRALEQALKIDANNLDALMGLAVSYTNEGYDSTSYRTLE 
                **:**  ** .*:*****: .* ***:.*.:*..* :*:  :::** ***** :::  *: 
                RWLDSKYPELT--RSPTID-----EANIDRFNLSKQVITKYLQVANALPQVDPEVQLGLG 
                KWAETKYPEIWS-RIKQQDDKFQKEKGFTHIDMNAHITKQFLQLANNLSTIDPEIQLCLG 
                RWLSVKYPQIINPNDVSSEADLGFTDRQLLHDRVTDLFIQAAQLSPSGEQMDPDVQVGLG 
                :* . ***::   .    :            :   .:  :  *::     :**::*: ** 
                TLFYANEEFGKTIDCFRTALEVNP----NDE----LMWNRLGASLANSNRSEEAIQAYHK 
                LLFYTKDDFDKTIDCFESALRVNP----NDE----LMWNRLGASLANSNRSEEAIQAYHR 
                VLFYCAEEYDKAVDCFSAALASTESGTSNQQEQLHLLWNRLGATLANSGRSEEAIEAYEQ 
                 ***  :::.*::*** :**  .     *::    *:******:****.******:**.: 
                ALALKPSFVRARYNLAISSMNIGCYKEAAESLLSALSMHEVEN----------VPITGSV 
                ALQLKPSFVRARYNLAVSSMNIGCFKEAAGYLLSVLSMHEVNT----------NNKKGDV 
                ALNINPNFVRARYNLGVSCINIGCYPEAAQHLLGALSMHRVVEQEGRERAREIVGGEGGI 
                ** ::*.********.:*.:****: ***  **..****.*                *.: 
                -------------VQSNNILETLKRSFVAMDRRDLLEKVMPGMDLQQFRNEFNF 
                GS--------LLNTYNDTVIETLKRVFIAMNRDDLLQEVKPGMDLKRFKGEFSF 
                DDEQLDRMIHVSQNQSTNLYDTLRRVFSQMGRRDLADQVVAGMDVNVFRREFEF 
                            . .: :**:* *  *.* ** ::* .***:: *: **.* 
BMC Biotechnology 2009, 9:48 http://www.biomedcentral.com/1472-6750/9/48determined the localization of the eGFP-PmpA fusion
protein by fluorescence microscopy. A similar punctated
pattern was observed as with the eGFP-SKL fusion con-
struct (figure 3), indicating that PmpA indeed can be used
as peroxisomal membrane anchor. Moreover the majority
of the eGFP-PmpA fusion protein is localised in peroxi-
somes. Since the SncA-PmpA fusion construct expressed
using the same GlaA promoter in identical expression cas-
settes, the majority of SncA-PmpA will be localised to per-
oxisomes as well, this is shown in figure 4). The v-SNARE
Snc1 in yeast, is intimately involved in fusion of Golgi
derived vesicles to the plasma membrane. We have iden-
tified an Snc1 ortholog in A. niger (sncA), and fused the
gene (without its transmembrane coding region) to pmpA.
When GFP-SKL and SncA-PmpA are co-overexpressed, a
clustering of peroxisomes is observed (figure 5). This clus-
tering is not observed when GFP-SKL is overexpressed
(figure 2). This indicates that the SncA part exposed to the
cytosol is interacting with itself thereby causing perx-
osimes to cluster. This behaviour of v-SNAREs has been
observed before [24] and could be enhanced when over-
expressed.
Using co-immunoprecipitaion we were able to identify
the A. niger homologue of fox2p as a partner of the SncA-
PmpA fusion protein (figure 6). Fox2p is a peroxisomal
protein involved in beta oxidation [25]. This is in line
with the data presented which indicates the peroxisomal
localisation of SNCA/PMPA.
Peroxicretion in A. niger
We cultivated A. niger co-expressing an SncA-PmpA fusion
protein and an SKL-tagged eGFP in MEAM cultures as
described in the materials and methods. After 24 hours,
only transformants containing SncA-PmpA secreted
eGFP-SKL into the extracellular medium, as evidenced by
Western blot analysis using anti GFP antibody (figure 7).
Expression of sncA-pmpA does not result in enhanced lev-
els of extracellular acetamidase activity (used as selection
marker), indicating that cell lysis is only limited. However
the peroxicretion efficiency was also determined and in
Peroxisomal localisation of eGFP-SKLFigure 2
Peroxisomal localisation of eGFP-SKL. Fluorescence microscopy was applied to determine the sub cellular localisation of 
eGFP-SKL. As shown in the right panel the SKL tagged eGFP is found in a punctuated pattern whereas eGFP without SKL is 
localised throughout the cytosol as shown in the left part of the panel.
Peroxisomal localisation of eGFP-PmpAFigure 3
Peroxisomal localisation of eGFP-PmpA. The eGFP 
tagged PmpA showed a similar localisation pattern compared 
to eGFP-SKL (figure 2), indicating that eGFP-PmpA also 
localises to peroxisomes.
eGFP-PmpA eGFP-PmpAPage 4 of 11
(page number not for citation purposes)
BMC Biotechnology 2009, 9:48 http://www.biomedcentral.com/1472-6750/9/48the peroxicretion strain, overexpressing SncA-PmpA and
eGFP-SKL, 55% of the total GFP was extracellular. When
we expressed only GFP-SKL we determined 25% of the
total GFP in the supernatant. This indicates that less than
50% of the extracellular GFP is due to lysis and more than
50% due to actual peroxicretion. We conclude that deco-
ration of peroxisomes with the v-SNARE SncA resulted in
fusion of peroxisomes with the plasma membrane, caus-
ing release of peroxisomal content in the extracellular
medium. The applicability of this approach to secrete
intracellular enzymes was further investigated using a set
of enzymes indicated in figure 8. We have expressed the
indicated proteins in wild type A. niger (panel A) and in a
peroxicreting A. niger (panel B), when indicated an SKL
tag was placed at the C terminus of the indicated proteins.
The amylase proteins (amyA and amyB) are also visible,
the presence of amyA is pH dependent. This explains why
amyA is not always visible. The peroxicretion strain shows
a slightly different acidification profile compared to the
wild type strain. Results clearly showed peroxicretion of 3
overexpressed putative peroxisomal proteins from a SncA-
PmpA expressing strain (figure 8). Using MS/MS we could
corroborate peroxicretion of at least one of those 3 pro-
teins (strong similarity to catalase/peroxidase CpeB,
(An01g01830)) and in addition identified one extra per-
oxicreted protein (similarity to endo-1,4-beta-xylanase
XynD, (An11g03120)). The relatively low abundance of
these proteins is likely to be caused by exposure to oxi-
Expression of the fusion peptide SncA-PmpAFigure 4
Expression of the fusion peptide SncA-PmpA. Cell 
free extracts were obtained from untransformed A. niger 
(lane 1) and from SncA-PmpA transformed A. niger (lane 2). 
The Cell free extracts were subjected to SDS-PAGE and 
western blotting according the manufacturers instructions 
(Invitrogen) and detection was performed using a custom 
made antibody against SncA protein (Eurogentec). The 
expected size of the SncA-PmpA fusion protein is 35 kDa.
188
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Co-expression of eGFP-SKL and SncA-PmpA in A. nigerFigure 5
Co-expression of eGFP-SKL and SncA-PmpA in A. 
niger. A. niger transformants were grown on MEAM as 
described in materials and methods. After 48 hours biomass 
was transferred to glass slides and subjected to fluorescence 
microscopy. The decoration of peroxisomes with the v-
SNARE SncA results in clustering of peroxisomes.
GFPskl , PMP/SNCFP-SKL , SNC1-PMP22eGFP-SKL and SncA-PmpA
Analysis of co-immunoprecipitation complexes using anti-SncA by SDS-PAGE and Sypro rubyFigure 6
Analysis of co-immunoprecipitation complexes using 
anti-SncA by SDS-PAGE and Sypro ruby. SDS-PAGE 
(4–12% Bis-Tris) gel loaded with the immunoprecipitation 
samples of wild type strain (lane 1) and peroxicretion strain 
(wild type strain transformed with SncA-PmpA fusion con-
struct) (lane 2) was stained with Sypro Ruby. The heavy and 
light chain of the used antibodies are running at 55 kDa and 
28 kDa. Proteins Differential bands were identified by MS/
MS.
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BMC Biotechnology 2009, 9:48 http://www.biomedcentral.com/1472-6750/9/48dised conditions combined with the presence of extracel-
lular proteases. It is evident that putative peroxisomal
proteins can be peroxicreted as well as cytosolic proteins
like the XynD orthologue. However the peroxisomal
enzymes have a higher success rate probably because they
are adapted to peroxisomal conditions in contrast to
cytosolic proteins. Simple C-terminal SKL addition is suf-
ficient to peroxicrete the XynD orthologue in SncA-PmpA
expressing cells. Proteins which contain a putative PTS1
sequence like the catalase/peroxidase CpeB orthologue
(An01g01830) and the alcohol oxidase orthologue
(An18g05480) could be peroxicreted without modifica-
tions. The peroxicreted alcohol oxidase shows enzymatic
activity in an H2O2 degrading assay, described in [26], and
depicted in figure 9. The wild type strain shows almost no
H2O2 degrading activity in the supernatant whereas the
peroxicretion strain shows an increasing in H2O2 degrad-
ing activity in the supernatant. This is most likely due to
peroxicretion of endogenous catalases/peroxidases local-
ised in peroxisomes.
Finetuning of peroxicretion
Fusion of peroxisomes with the plasma membrane was
supported using electron microscopy. Inspection of
ultrathin section of KMnO4-fixed cells revealed that per-
oxisomes were frequently located in close vicinity of the
cell membrane and often showed continuation with this
membrane (figure 10A, B, C.). This was never observed in
wild type cells without SncA-PmpA expression in which
the organelles are scattered throughout the cytosol but are
not seen in close proximity of the cell membrane (figure
10D). The efficiency of peroxicretion is likely to be con-
trolled at the level of SNARE-pin formation during mem-
brane fusion. In order to increase this efficiency of SNARE
pin formation we have truncated the cytoplasmic tail of
PmpA in order to place the v-SNARE SncA in closer prox-
imity to the peroxisomal membrane. The peroxicretion
efficiency is reduced when the N-terminus of PmpA is
truncated with more than 18 amino acids, probably due
to mislocalization (figure 11).
Another way of increasing the peroxicretion efficiency is
to use C2 ceramide. Activation of CAPP by adding C2-
ceramide is known to result in increased availability of t-
SNARE, Sso1p, which is important for SNARE-pin forma-
tion [26,27]. Indeed, addition of C2-ceramide slightly
enhanced the peroxicretion efficiency (figure 12). A third
Secretion of eGFP-SKL mediated by SncA decorated peroxi-som sFigure 7
Secretion of eGFP-SKL mediated by SncA decorated 
peroxisomes. A. niger strains were cultivated for 24 hours 
in MEAM. 10 ul samples of the medium were taken and sub-
jected to SDS-PAGE and subsequently to western blotting as 
indicated by the manufacturer (Invitrogen). Lane 1: positive 
control eGFP, lane 2: MW marker indicated at the right hand 
side, lane 3 and 4: eGFP-SKL transformants, lane 5 and 6: 
eGFP-SKL, SNCA-PMPA co-transformants, lane 7 and 8: 
untransformed wild type strain.
97kD
64kD
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Peroxicretion of putative peroxisomal proteinsFigure 8
Peroxicretion of putative peroxisomal proteins. SDS-
PAGE analysis of shake-flask samples of the control strains 
(panel A) and peroxicreting strains (panel B), peroxicreting 
different intracellular A. niger enzymes as indicated. When 
indicated an SKL sequence was added to the C terminus of 
the protein. After SDS-PAGE the cells were stained with 
coomassie brilliant blue. Endogenous amylases are indicated. 
The strains were grown for four days at 30°C, 250 rpm In 
MEAM. Supernatant was isolated and loaded on a Nupage 
gel. Lane 1: strong similarity to catalase/peroxidase CpeB, 84 
kDa (An01g01830), lane 2: strong similarity to chitinase 1 
precursor Cts1, 48 kDa (An02g07020) an SKL sequence was 
added to the C terminus of the protein, lane 3: strong simi-
larity to alpha-amylase precursor AmyA, 60 kDa 
(An09g03100) an SKL sequence was added to the C terminus 
of the protein, lane 4: strong similarity to lipase LipP, 37 kDa 
(An09g06390) an SKL sequence was added to the C terminus 
of the protein, lane 5: similarity to endo-1,4-beta-xylanase 
XynD, 35 kDa (An11g03120) an SKL sequence was added to 
the C terminus of the protein, lane 6: strong similarity to D-
amino acid oxidase Dao1, 41 kDa (An14g05380) an SKL 
sequence was added to the C terminus of the protein, lane 7: 
show strong similarity to several fungal alcohol oxidases, 74 
kDa (An18g05480).
A B
1     2     3     4     5     6     7 1     2     3     4     5     6     7MW
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BMC Biotechnology 2009, 9:48 http://www.biomedcentral.com/1472-6750/9/48approach to increase the efficiency of peroxicreion is to
increase the number of peroxisomes. Overexpression of
the A. niger ortholog of Pex11, which is known to be
involved in peroxisomal proliferation [21] only resulted
in minor peroxisomal proliferation in the A. niger trans-
formants, while peroxicretion was not enhanced (figure
13). This may be explained by the fact that the increase in
organelle numbers is not associated with a concomitant
increase in matrix protein levels.
Discussion
In this study the v-SNARE SncA without its transmem-
brane domain was placed on the peroxisome using PmpA
as a membrane anchor. The transmembrane domain of
Snc1p is reported to be important for its function [28].
However, replacing the SncA-TMD by PmpA did not
diminish the potential of SncA to enforce membrane
fusion, since the peroxisomal content was released in the
extracellular environment. PmpA as membrane anchor is
sufficient for SncA to bring the membrane bilayers in close
contact so that spontaneous membrane fusion occurs. We
have selected peroxisomes because they can import com-
pletely folded proteins, which makes them ideally suited
to transport and secrete proteins which are normally are
localized intracellular. Recently, convincing evidence was
presented that peroxisomes may originate from the ER
[16]. This is important since the lipid composition of per-
Enzymatic activity of peroxicreted alcohol oxidaseFigure 9
Enzymatic activity of peroxicreted alcohol oxidase. 
Using 100 μl of supernatant of shakeflask grown A. niger cul-
tures the degradation of 0.1% H2O2 was monitored in 2 ml 
milliQ by measuring absorption at 240 nm. (black triangle) 
represents the H2O2 degrading activity of 100 μl supernatant 
of the wild type strain, (black circle) represents the H2O2 
degrading activity of 100 μl supernatant of the peroxicretion 
strain and (black square) represents the H2O2 degrading 
activity of 100 μl supernatant of the peroxicretion strain 
overexpressing gene ID 4990113 which shows strong similar-
ity with several alcohol oxidases.
H2O2 degradation
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Survey of hyphal cells showing the position of a peroxisome (arrow) in the vicinity of the cell membrane in SncA-PmpA expr ssing A. nigerFigure 10
Survey of hyphal cells showing the position of a peroxisome (arrow) in the vicinity of the cell membrane in 
SncA-PmpA expressing A. niger. Panel A. Lengthwise overview of cellular membranes in SncA-PmpA expressing A. niger. 
Arrow indicates continuity of peroxisomes with the cell membrane (high magnification in panel A1). Panel B. Crosswise over-
view of cellular membranes in SncA-PmpA expressing A. niger. Arrow indicates continuity of peroxisomes with the cell mem-
brane (high magnification in panel B1). Panel C. Schematic representation of the release of the peroxisomal content due to 
fusion of the peroxisome with the plasmamembrane. The target SNARE (Sso1 ortholog) is shown in yellow as a transmem-
brane protein. The chimeric protein SncA-PmpA is depicted in blue (PmpA part) and red (SncA part). For simplicity Sec9 
ortholog is not shown. The release of peroxisomal content is depicted, demonstrating peroxicretion of SKL tagged proteins (in 
green). Panel D. Detail of a glucose-grown A. niger WT cell, showing the presence of peroxisomes that are randomly scattered 
in the cytosol. M-mitochondrion, N – nucleus, P – peroxisomes, V-vacuole.
C
D
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BMC Biotechnology 2009, 9:48 http://www.biomedcentral.com/1472-6750/9/48oxisomes now is likely to be comparable to that of other
ER/Golgi derived organelles like other secretory vesicles.
Because of this similarity in lipid composition it appears
unlikely that lipid incompatibility between peroxisomes
and the plasma membrane would present a major hurdle
for peroxicretion. Moreover, the small GTPase Rho1 is
localized on peroxisomes through interaction with the
peroxisomal membrane protein Pex25 [29]. Rho1p is
known to play a role in actin reorganization and mem-
brane dynamics. In yeast, Rho1 regulates polarized
growth, and in the filamentous fungus A. niger polarized
growth is even more predominant. In Arabidopsis, trans-
portation of peroxisomes by actin filaments is reported
[30] similar to transportation of secretory vesicles. This
would be a possible mechanism how peroxisomes are
able to be transported intracellular, Snc1 decorated perox-
isomes are able to fuse with the plasmamembrane. The
examples of Peroxicretion as described in this paper,
shows that positioning of SncA on the peroxisomal mem-
brane is sufficient for fusion of the peroxisome with the
plasma membrane and subsequent release of its cargo.
Interestingly, all these findings strengthen the notion that
peroxisomes are derivatives of the secretory pathway. This
renders peroxisomes as attractive vehicles for the transport
of intracellular proteins towards the plasma membrane
and secretion into the extracellular medium. It is however
not excluded that peroxismes fuse to other intracellular
compartments like endosomes before actual fusion with
the plasmamebrane takes place. It is very likely that not all
peroxisomes will be fused to the cellmembrane since the
localization of PmpA fused proteins is not absolutely per-
oxisomal. In addition we do not observe decreased
growth under conditions were peroxisomes are expected
to be important. It is more likely that the peroxicretion
concept as presented in this paper is not yet very efficient
and that several key steps in the process like fusion of per-
oxisomes with the cell membrane, peroxisomal import of
Overexpression of PEX11 ortholog leads to increased per-oxisomal proliferation in A. nigerFigure 13
Overexpression of PEX11 ortholog leads to 
increased peroxisomal proliferation in A. niger. PEX11 
ortholog overexpression leads to a minor increase in the 
number of peroxisomes however the peroxisomes seems to 
be smaller compared to the strain where only eGFP-SKL was 
expressed.
GFP-SKL GFP-SKL,PEX11
Mean fluorescence of eGFP-SKL overexpressing strains con-taini g different truncated SncA-PmpA constructFigure 11
Mean fluorescence of eGFP-SKL overexpressing 
strains containing different truncated SncA-PmpA 
constructs. Fluorescence of individual samples was meas-
ured in supernatant of MTP cultures. SD is indicated as well 
as the number of transformants which were analysed.
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Ceramide stimulates peroxicretion, overexpression of PEX11 ortholog (An11g02590) does notFigure 12
Ceramide stimulates peroxicretion, overexpression 
of PEX11 ortholog (An11g02590) does not. 10 μl of 
supernatant after 48 hours growth of the strains transformed 
with the indicated constructs at 30°C, 250 rpm in MEAM. 
Lane 1; eGFP-SKL, lane 2; eGFP-SKL and C2 ceramide, lane 
3; eGFP-SKL (duplo of lane 1), lane 4; MW, lane 5; eGFP-SKL 
and SncA-PmpA, lane 6; eGFP-SKL, C2 ceramide and SNCA-
PMPA, lane 7; eGFP-SKL, SncA-PmpA and PEX11 ortholog, 
lane 8; eGFP-SKL, C2 ceramide, SncA-PmpA and PEX11 
ortholog lane 9; WT, lane 10; WT and C2 ceramide.
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have to be improved.
Conclusion
This paper shows that it is possible to redirect intracellular
trafficking of organelles by re-localizing v-SNARE mole-
cules. The decoration of target organelles with selected v-
SNARE proteins is facilitated by using a modified mem-
brane anchor which positions the v-SNARE onto the
membrane of the target vesicle. This technology opens up
numerous possibilities for studying intracellular vesicle
trafficking in vivo. Besides this fundamental application
the redirection of intracellular organelles also can be used
in industrial biotechnology. As demonstrated in this
paper, the targeting of proteins towards peroxisomes by
using a C-terminal SKL sequence followed by fusion of
modified peroxisomes with the plasmamembrane results
in secretion of intracellular proteins. This process is desig-
nated peroxicretion. Although the levels of the peroxi-
creted products are still very low it shows the potential of
the peroxicretion technology.
Methods
Constructs, strains and transformation
Standard molecular cloning techniques were performed. The
constructs pGBFINSNP-2 to 5 contain the v-SNARE named
sncA (An12g07570), fused to the N-terminal 318, 300, 285,
or 275 amino acids of the peroxisomal membrane protein
pmpA (An04g09130) respectively. The sncA-pmpA fusion
gene is deposited as: GenBank DQ768214. Both genes were
obtained by PCR on genomic DNA and the obtained nucle-
otide sequence was confirmed by sequencing (Baseclear, Lei-
den). The vector pGBFINGFS-1 contains eGFP with the
amino acids SKL added to the C-terminus. The nucleotide
sequence (5'-TCCAAGCTC-3') encoding for the amino acids
SKL was introduced at the C-terminus of eGFP by PCR. The
construct pGBFINGFM-2 (GenBank DQ768213) was
obtained by translational fusion of the eGFP and pmpA ORF
through PCR. The pGBFIN vector was also used for overex-
pression of different genes (An01g01830, An02g07020,
An09g03100, An09g06390, An11g03120, An14g05380 and
An18g05480). Using primers which were extended by 9
nucleotides encoding SKL the protein encoding sequences of
An02g07020, An09g03100, An09g06390, An11g03120 and
An14g05380 were modified at the C terminus. All of the
above A. niger expression constructs are driven by the strong
glucoamylase promoter and harbour flanking regions to
ensure convenient targeting and expression in the fungal
host as described previously [31]. Subsequent transforma-
tion of A. niger strain CBS 513.88 with the expression con-
structs was performed as previously described [32].
Culture methods
A. niger strains were inoculated at 5 × 106 spores/ml
MEAM consisting of: 6 g NaNO3; 0.52 g KCl; 1.52 g
KH2PO4; 1.12 ml 4 M KOH; 0.52 g MgSO4 .7H2O; 10 g
glucose; 1 g casaminoacids; 22 mg g ZnSO4 .7H2O; 11 mg
H3BO3; 5 mg FeSO4 .7H2O; 1.7 mg CoCl2. 6H2O; 1.6 mg
CuSO4. 5H2O; 1.5 mg Na2MoO4. 2H2O; 50 mg EDTA; 5
mg MnCl2. 2H2O; 2 mg riboflavin; 2 mg thiamin-HCl; 2
mg nicotinamid; 1 mg pyrodoxin-HCl; 0.2 mg pan-
tothenic acid; 4 μg biotin;10 ml penicillin/streptomycine
(Invitrogen) per liter. The strains were grown at 30°C and
250 rpm for 1–3 days. When required conidiospores were
obtained by growth on Potato Dextrose Agar (PDA,
Oxoid, England) for 5 days at 30°C, and isolated with
MilliQ and a spatula.
Western blot analysis
SDS-PAGE was performed using NuPAGE Novex Bis-Tris
precast gels (Invitrogen) according to the supplier's man-
ual. Proteins were visualized by staining with SimplyBlue
SafeStain (Invitrogen). Western analysis was performed
with the XCell II semi-wet blotting module (Invitrogen)
using MOPS buffer and nitrocellulose membrane (0.45
μm pore size) according to the supplier's manual. GFP
was specifically detected by using 1:1,000 fold diluted
GFP monoclonal antibody (Covance, California). After
incubation with secondary antibody conjugated to horse-
radish peroxidase (anti-mouse, 1:1,000 dilution,
PIERCE), immunoreactive proteins were detected by the
enhanced chemiluminescence system (ECL, Amersham
Pharmacia) and exposed to radiographic film (Kodak).
The SNC 1 westerns were prepared similar to the proce-
dure described above with the expection that the anti-
SNC1 antibody was custom made by Eurogentec.
Immunoprecipitation of SncA-pmpA
Frozen cells were disrupted in a mortar filled with liquid
nitrogen and suspended in 0.5 ml 20 mM Sodium-Phos-
phate, 1% TritonX-100, 1 mM EDTA, and protease inhib-
iter. Cell lysate was voraciously vortexed and placed on ice
for 10 minutes. TritonX-100 induces lyses of A. niger. The
cell lysate was centrifuged for 5 minutes at 13.000 g and
supernatant was taken. A pre-clearance step with 25 μl was
used to reduce the background of a-specific bonding to
Protein-A-Sepharose (10% Protein-A-Sepharose in 20
mM Sodium phosphate pH 7,4, 1 mM EDTA, 0,1% Triton
X-100). The soluble fraction was incubated with Protein-
A-Sepharose and rotated head over head for 1 hour at
4°C. The supernatant was incubated with 2.5 μl 10-5
diluted antibody SNC α-SNC (serum 2e booster NL
03077, rabbit no = SN1391) for 1 hour at 4°C to bind the
SNC for 1 hour at 4°C. In total 25 μl Protein-A-Sepharose
was added to the sample to bind antibody SNC with
bounded SNC and the incubation was extended for again
one hour. Protein-A-Sepharose was used to facilitate spin-
down antibody SNC with bounded SNC. To remove the
remaining antibody, Protein-A-Sepharose and the not
bound proteins, the sample was washed once for 5 min-Page 9 of 11
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tonX-100, 1 mM EDTA, and protease inhibiter. The
samples were treated with 25 μl sample buffer and 5 μl
reducing agent. After heating the samples for 5 minutes at
95°C and centrifuging, 20 μl supernatant was loaded on
the 4%–12% SDS-PAGE gel. After electrophoresis, Sypro
Ruby staining was performed. For 24 hours the gel was
stained in 100 ml Sypro Ruby staining. After staining, the
gel was washed once with MilliQ. Instead of a Coomassie
blue staining the gel was stained with a Sypro Ruby,
because this is more sensitive. Sypro ruby does not need
to be destained, because the dye does not bind irreversible
to proteins and is therefore washable from the sample
(Patton, 2000). The fragments were cut out of the gel and
identified by mass-spectrometry.
Microscopy
For analysis of eGFP localization the fungal cells were
grown at 30°C in MEAM for 1–2 days. Mycelium was
transferred to microscope coverslides and studied under a
Leica DMLA microscope connected to a CTRMIC unit. The
apparatus was controlled by Qwin software from Leica.
Electron microscopy was performed as described before
[33].
Digestion and LC-MS/MS analysis
The sups were filtered over centrifugal devices (Pall) in
tubes. Proteins with MW >100 kDa were filtered over 100
kDa centrifugal devices, proteins with MW 30–100 kDa
were filtered over 30 kDa centrifugal devices and proteins
with MW 10–30 kDa were filtered over 10 kDa centrifugal
devices. 500 μL MQ was added on the filters and again the
samples were centrifuged at 13000 rpm 4°C for 15 min-
utes. 150 μL 80 mM NH4HCO3 was added to the retentate
of each of the samples after filtration and the retentate was
transferred to 1.5 mL eppendorf tubes after pipetting up
and down on the filter a couple of times. The proteins
were denatured by incubation at 97°C for 10 minutes.
350 μL 80 mM NH4HCO3 and 20 μL 250 μg/mL trypsin
were added and the proteins were digested by incubation
at 37°C over night. 6 μL 100 mM DTT was added and the
samples were incubated at room temperature for 30 min-
utes. LC-MS/MS was performed on the CapLC-QTOFII
(Waters) system. For each of the samples a different MS/
MS method was made with the selected precursors for the
over-expressed proteins. For each of the precursors theo-
retical fragmentation (MS/MS) spectra were made using
Masslynx software (Waters) and the LC-MS/MS data was
compared to these theoretical fragmentation spectra.
Quantification of fluorescence
Approximately 1 × 105 conidiospores were inoculated in
300 μl MEAM (vitamins were omitted because of interfer-
ence with the fluorescence measurements) per MTP well.
After 5 days incubation at 30°C in an MTP (Nunc) the
medium was separated from the mycelium and 200 μl
was transferred to a new MTP (Greiner, Fluotrac 200).
Subsequently the fluorescence was measured on a Gemini
spectra MAX (Molecular devices) controlled by SOFT max
PRO v3.1.1 (Molecular Devices) using an excitation wave-
length of 490 nm and an emission wavelength of 510 nm.
Additional settings: cut-off 495 nm, PMT auto, calibrate
on, 6 reads per well, 9 points per well. The amount of
eGFP-SKL was determined in RFUs (relative fluorescent
units).
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